SI9820009A - Novi etilaminski derivati - Google Patents
Novi etilaminski derivati Download PDFInfo
- Publication number
- SI9820009A SI9820009A SI9820009A SI9820009A SI9820009A SI 9820009 A SI9820009 A SI 9820009A SI 9820009 A SI9820009 A SI 9820009A SI 9820009 A SI9820009 A SI 9820009A SI 9820009 A SI9820009 A SI 9820009A
- Authority
- SI
- Slovenia
- Prior art keywords
- compound
- carbon atoms
- compounds
- propylaminopentane
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24744597 | 1997-08-07 | ||
PCT/JP1998/003468 WO1999007667A1 (fr) | 1997-08-07 | 1998-08-03 | Nouveaux derives d'ethylamine |
Publications (1)
Publication Number | Publication Date |
---|---|
SI9820009A true SI9820009A (sl) | 1999-10-31 |
Family
ID=17163558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9820009A SI9820009A (sl) | 1997-08-07 | 1998-08-03 | Novi etilaminski derivati |
Country Status (17)
Country | Link |
---|---|
US (1) | US6214859B1 (es) |
EP (1) | EP0957080B1 (es) |
JP (1) | JP4569980B2 (es) |
KR (1) | KR100572900B1 (es) |
CN (1) | CN1182103C (es) |
AT (1) | ATE330930T1 (es) |
AU (1) | AU747737B2 (es) |
CA (1) | CA2267315C (es) |
DE (1) | DE69835004T2 (es) |
DK (1) | DK0957080T3 (es) |
ES (1) | ES2267190T3 (es) |
HK (1) | HK1022682A1 (es) |
HU (1) | HU228759B1 (es) |
IL (1) | IL129322A (es) |
PT (1) | PT957080E (es) |
SI (1) | SI9820009A (es) |
WO (1) | WO1999007667A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4499208B2 (ja) * | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | 新規な光学活性アミノペンタン誘導体 |
FR2792313A1 (fr) * | 1999-04-13 | 2000-10-20 | Synthelabo | Derives de 2-aminoethyl-indole, leur preparation et leur application en therapeutique |
JP2003505369A (ja) * | 1999-07-15 | 2003-02-12 | エヌピーエス アレリックス コーポレーション | 偏頭痛を治療するための複素環式化合物 |
JP4691230B2 (ja) * | 2000-04-11 | 2011-06-01 | 株式会社フジモト・コーポレーション | 光学活性1−(ベンゾフラン−2−イル)−2−プロピルアミノペンタンの製造方法 |
SE0001438D0 (sv) * | 2000-04-18 | 2000-04-18 | Axon Chemicals Bv | New chemical compounds and their use in therapy |
JP4888751B2 (ja) * | 2001-09-14 | 2012-02-29 | 株式会社フジモト・コーポレーション | トリフルオロプロピルアミノペンタン誘導体及びその製造方法 |
JP4953041B2 (ja) * | 2001-09-19 | 2012-06-13 | 株式会社フジモト・コーポレーション | アポトーシス抑制剤 |
US6991911B2 (en) * | 2003-12-15 | 2006-01-31 | Dade Behring Inc. | Assay for entactogens |
US20050130243A1 (en) * | 2003-12-15 | 2005-06-16 | Zheng Yi F. | Assay for entactogens |
US7022492B2 (en) * | 2003-12-15 | 2006-04-04 | Dade Behring Inc. | Ecstasy haptens and immunogens |
US7037669B2 (en) * | 2004-03-22 | 2006-05-02 | Dade Behring Inc. | Assays for amphetamine and methamphetamine using stereospecific reagents |
US7115383B2 (en) * | 2004-03-22 | 2006-10-03 | Dade Behring Inc. | Assays for amphetamine and methamphetamine |
CA2642264A1 (en) | 2006-02-13 | 2007-08-30 | Trustees Of Boston University | Reca inhibitors with antibiotic activity, compositions and methods of use |
US20100137429A1 (en) * | 2007-06-21 | 2010-06-03 | Fujimoto Co., Ltd. | Composition for transdermal or transmucosal administration |
KR20150013476A (ko) * | 2012-04-04 | 2015-02-05 | 아이백스 인터내셔널 게엠베하 | 조합요법용 약학적 조성물 |
BR112016014236A2 (pt) | 2013-12-25 | 2017-08-08 | Fujimoto Co Ltd | Agente profilático e terapêutico para o distúrbio do déficit de atenção/hiperatividade |
US10258598B2 (en) | 2014-12-05 | 2019-04-16 | Semmelweis University | Compounds for use in the prevention or treatment of cancer |
CN114028616A (zh) * | 2021-09-28 | 2022-02-11 | 遵义医科大学 | 一种用于牙槽骨缺损修复的组织工程化材料制备方法 |
WO2024064825A1 (en) * | 2022-09-21 | 2024-03-28 | Axsome Therapeutics, Inc. | Compounds and combinations thereof for treating neurological and psychiatric conditions |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB855115A (en) * | 1958-07-11 | 1960-11-30 | Smith Kline French Lab | Improvements in or relating to ª‰-aminoalkylthianaphthene and ª‰-aminoalkylbenzofuran derivatives |
GB901919A (en) * | 1959-02-12 | 1962-07-25 | Upjohn Co | Therapeutic compositions comprising alpha-alkyl-tryptamines |
GB893707A (en) * | 1960-03-01 | 1962-04-11 | Roche Products Ltd | Novel tryptamine derivatives and a process for the manufacture thereof |
FR1344579A (fr) * | 1961-11-23 | 1963-11-29 | Sandoz Sa | Nouveaux dérivés de l'indole et leur préparation |
US3296072A (en) * | 1962-06-11 | 1967-01-03 | Upjohn Co | Method of treating mental depression |
US3472870A (en) | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
US3883560A (en) | 1973-07-05 | 1975-05-13 | Colgate Palmolive Co | Salicylamidophenethanolamines |
FR2536749A1 (fr) * | 1982-11-25 | 1984-06-01 | Cerm Cent Europ Rech Mauvernay | (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique |
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
US5220068A (en) * | 1986-09-25 | 1993-06-15 | Chinoin Gyogyszer - Es Vegyeszeti Termekek Gyara Rt. | Psychostimulant agent |
TW270114B (es) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
US5627200A (en) * | 1994-09-26 | 1997-05-06 | Pfizer Inc | β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia |
FR2729147A1 (fr) * | 1995-01-11 | 1996-07-12 | Adir | Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734814B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734816B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB9702310D0 (en) | 1997-02-05 | 1997-03-26 | Univ Hertfordshire | Invention |
-
1998
- 1998-08-03 KR KR1019997003005A patent/KR100572900B1/ko not_active IP Right Cessation
- 1998-08-03 US US09/269,718 patent/US6214859B1/en not_active Expired - Lifetime
- 1998-08-03 ES ES98935352T patent/ES2267190T3/es not_active Expired - Lifetime
- 1998-08-03 SI SI9820009A patent/SI9820009A/sl not_active IP Right Cessation
- 1998-08-03 EP EP98935352A patent/EP0957080B1/en not_active Expired - Lifetime
- 1998-08-03 CN CNB988011190A patent/CN1182103C/zh not_active Expired - Fee Related
- 1998-08-03 AT AT98935352T patent/ATE330930T1/de active
- 1998-08-03 WO PCT/JP1998/003468 patent/WO1999007667A1/ja active IP Right Grant
- 1998-08-03 JP JP51196699A patent/JP4569980B2/ja not_active Expired - Fee Related
- 1998-08-03 DE DE69835004T patent/DE69835004T2/de not_active Expired - Lifetime
- 1998-08-03 PT PT98935352T patent/PT957080E/pt unknown
- 1998-08-03 DK DK98935352T patent/DK0957080T3/da active
- 1998-08-03 IL IL12932298A patent/IL129322A/en not_active IP Right Cessation
- 1998-08-03 CA CA002267315A patent/CA2267315C/en not_active Expired - Fee Related
- 1998-08-03 AU AU84635/98A patent/AU747737B2/en not_active Ceased
- 1998-08-03 HU HU0001466A patent/HU228759B1/hu not_active IP Right Cessation
-
2000
- 2000-03-09 HK HK00101470A patent/HK1022682A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1236356A (zh) | 1999-11-24 |
IL129322A0 (en) | 2000-02-17 |
ES2267190T3 (es) | 2007-03-01 |
HUP0001466A3 (en) | 2001-09-28 |
DE69835004D1 (de) | 2006-08-03 |
IL129322A (en) | 2004-02-19 |
CN1182103C (zh) | 2004-12-29 |
EP0957080B1 (en) | 2006-06-21 |
PT957080E (pt) | 2006-10-31 |
HUP0001466A2 (hu) | 2001-05-28 |
EP0957080A4 (en) | 2004-10-20 |
HK1022682A1 (en) | 2000-08-18 |
AU8463598A (en) | 1999-03-01 |
KR20000068728A (ko) | 2000-11-25 |
AU747737B2 (en) | 2002-05-23 |
DK0957080T3 (da) | 2006-10-23 |
WO1999007667A1 (fr) | 1999-02-18 |
KR100572900B1 (ko) | 2006-04-24 |
DE69835004T2 (de) | 2007-03-01 |
JP4569980B2 (ja) | 2010-10-27 |
HU228759B1 (en) | 2013-05-28 |
CA2267315C (en) | 2008-01-08 |
EP0957080A1 (en) | 1999-11-17 |
US6214859B1 (en) | 2001-04-10 |
CA2267315A1 (en) | 1999-02-18 |
ATE330930T1 (de) | 2006-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI9820009A (sl) | Novi etilaminski derivati | |
US6008233A (en) | (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate | |
US20070203120A1 (en) | Sulfonyl Substituted 1H-Indoles as Ligands for the 5-Hydroxytryptamine Receptors | |
HU185475B (en) | Process for preparing /-/-n-methyl-3-/2-methyil-phenoxy/-3-phenyl-propyl-amine and salts thereof | |
JP2020502184A (ja) | 疼痛および疼痛に関連する状態を処置するための新規なキノリンおよびイソキノリン誘導体 | |
SK282944B6 (sk) | Tavené tropánové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie | |
JPH06179681A (ja) | 置換されたアミノチエノピリジン、それらの製法および医薬としてのそれらの使用 | |
US7009051B2 (en) | 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity | |
US20200207759A1 (en) | New propanamine derivatives for treating pain and pain related conditions | |
US8637551B2 (en) | 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives | |
US8168646B2 (en) | 3,4-dihydroquinazoline derivatives | |
Romero et al. | Inhibitors of Phenylethanolamine N-Methyltransferase That Are Predicted To Penetrate the Blood− Brain Barrier: Design, Synthesis, and Evaluation of 3-Fluoromethyl-7-(N-substituted aminosulfonyl)-1, 2, 3, 4-tetrahydroisoquinolines That Possess Low Affinity toward the α2-Adrenoceptor | |
AU762995B2 (en) | Novel optically active aminopentane derivative | |
CA2222573A1 (en) | The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence | |
HRP20030608A2 (en) | Use of gal3 receptor antagonists for the treatment | |
KR20070061846A (ko) | 신규한 크로멘-2-온 유도체 및 모노아민 신경전달물질재흡수 억제제로서의 이의 용도 | |
MXPA01012449A (es) | Derivados de acilaminciclopropano. | |
KR100276994B1 (ko) | 아릴알콕시페녹시-이미다졸린화합물 | |
TW317565B (es) | ||
EP0940386A1 (fr) | Nouveaux composés du benzocyclobutane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
CN115960032A (zh) | 具有β-arrestin偏向性激动活性的芳氧丙醇胺类β-肾上腺素受体配基及其用途 | |
CA2327513A1 (en) | N-aryloxyethyl-indoly-alkylamines for the treatment of depression | |
US20030191314A1 (en) | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors | |
Tucker | Studies toward the Synthesis of Analogues of the Marine Neurotoxins, Tetrodotoxin and Saxitoxin | |
MXPA00012609A (es) | Derivados de 4,5,6 y7-indol e indolina, su prepracion y uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF | Valid on the event date | ||
OU01 | Decison according to article 73(1) ipa 1992, publication of decision on fulfilment of conditions on patentability |
Effective date: 20061122 |
|
SP73 | Change of data on owner |
Owner name: FUJIMOTO CO., LTD.; JP Effective date: 20101020 |
|
KO00 | Lapse of patent |
Effective date: 20150317 |